Treatment of deficient forms of schizophrenia - Discussion

被引：0
作者：
Vandel, P. [1 ]
机构：
[1] CHU St Jacques, F-25000 Besancon, France
来源：
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 2007年
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 4 条
[1]   A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia [J].
Evins, AE ;
Cather, C ;
Deckersbach, T ;
Freudenreich, O ;
Culhane, MA ;
Olm-Shipman, CM ;
Henderson, DC ;
Schoenfeld, DA ;
Goff, DC ;
Rigotti, NA .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) :218-225
[2]   A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [J].
Fatemi, SH ;
Stary, JM ;
Hatsukami, DK ;
Murphy, SE .
SCHIZOPHRENIA RESEARCH, 2005, 76 (2-3) :353-356
[3]  
Ferreri F, 2006, J PSYCHIATR NEUROSCI, V31, P369
[4]   A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics, for the cognitive impairments in chronic schizophrenia [J].
Lee, Sae-Woom ;
Lee, Jung-Goo ;
Lee, Bong-Ju ;
Kim, Young Hoon .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) :63-68
1